Navigation Links
Anesiva Announces Hiring of Sales Force for FDA-Approved Product Zingo(TM)
Date:1/30/2008

tions.

Anesiva's 15 Regional Account Managers (RAMs) also have a significant amount of tenure and previous success driving formulary additions and uptake in the hospital market. On average, they have 14 years of selling experience, 9 in the hospital arena. The RAMs are located in geographic areas in the United States that have significant concentrations of pediatric hospitals. These institutions perform the majority of the 18 million annual peripheral venous access procedures in children ages three to 18. The RAMs have completed training and are now deployed into their territories.

About Zingo

Zingo provides topical, local analgesia to reduce the pain associated with peripheral IV insertions or blood draws, and is FDA-approved for use in children three to 18 years of age. Zingo is an easy-to-administer, single-use, needle-free system containing 0.5 mg sterile lidocaine powder. It provides rapid onset of action, allowing intravenous line placement or venipuncture to begin one to three minutes after administration.

In two pivotal, multicenter, randomized, double-blind, placebo-controlled clinical studies, a total of 1,114 pediatric patients in the U.S., Zingo demonstrated a statistically significant reduction in procedural pain compared to placebo. In the clinical trials, the most common adverse events were redness (erythema), red dots (petechiae) and swelling (edema) at the site of administration.

About Anesiva and its Diverse Pipeline of Pain Products

Anesiva, Inc. is a late-stage biopharmaceutical company that seeks to be the leader in the development and commercialization of novel pharmaceutical products for pain management. The company has one FDA-approved product, Zingo(TM), for the reduction of pain associated with peripheral venous access procedures in children ages three to 18. The second product in Anesiva's pipeline, Adlea(TM), has been shown to reduce pain after only a single administration for weeks to months in m
'/>"/>

SOURCE Anesiva, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Anesiva to Unveil Zingo(TM) Commercialization Plans
2. Anesiva to Present at BIO InvestorForum on October 11, 2007
3. Anesiva to Announce Third Quarter 2007 Financial Results and Host Webcast Conference Call on November 1, 2007
4. Anesiva Announces Upcoming Webcasts and Conference Participation
5. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
6. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
7. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
8. HEI, Inc. Announces Sale of RFID Division Assets
9. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
10. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
11. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... Mountain Point Medical Center, a campus of ... on Friday, May 29, 2015 at 11 a.m., followed by ... new medical center, set to officially open on June 1, ... 84043. , “The opening of Mountain Point Medical Center ... County community,” said Kent Loosle, CEO of Mountain Point Medical ...
(Date:5/22/2015)... Omar Ahmad Barrada, a junior at Milton ... 2015 Congress of Future Medical Leaders in Boston, Mass. ... “America’s highest achieving high school students.” , “I’m excited ... goals and learn better study habits,” said Omar. “The ... we can ask the surgeons questions.” , The goal ...
(Date:5/22/2015)... 2015 Family, friends, students, colleagues, mentors ... oncologist, Dr. LaSalle D. Leffall, on Monday, May 18, ... after Grand Rounds in the hospital’s Tower Auditorium. Leffall’s ... the auditorium, trying to keep the secret. “I’d like ... sees me, he’ll know something is up,” she said. ...
(Date:5/22/2015)... WA (PRWEB) May 22, 2015 According to ... of all generations are equally as likely to worry about ... Millennials, 75% Gen X, 77% Boomers, 69% Silent Generation), which ... agree they are scared of aging, particularly Millennials (47%), Gen ... by Harris Poll in April, 2015 among more than 2,000 ...
(Date:5/22/2015)... According to Berks and Beyond , Pennsylvania ... totaling almost 2,500 confirmed drug deaths, as reported on May ... 2,489 deaths stemming from legal and illegal drug use in ... every day to fatal overdoses or other drug related deaths. ... of the most rife with drug related deaths. The city, ...
Breaking Medicine News(10 mins):Health News:Mountain Point Medical Center, a Campus of Jordan Valley Medical Center, Hosts Ribbon Cutting Ceremony and Community Celebration on Friday, May 29, 2015 2Health News:Milton Hershey School Student Chosen for Congress of Future Medical Leaders 2Health News:Colleagues Surprise Dr. LaSalle Leffall with 85th Birthday Celebration 2Health News:New Study Reveals America’s Fear of Aging 2Health News:New Study Reveals America’s Fear of Aging 3Health News:Philadelphia Ranks Among the Tops Cities in Penn. for Drug Deaths 2
... service helps Medicare beneficiaries avoid loss of ... to pay for prescription medications, ARLINGTON, Va., Oct. ... services, and Human Arc (Cleveland, OH),a leading expert in ... Medicare Part D plan sponsors,retained their services to redeem ...
... SAN FRANCISCO While some targeted therapies ... chemical pathways occurring within cancer cells work well ... better when teamed with other targeted and conventional therapies. ... on Molecular Targets and Cancer Therapeutics, multiple-target applications of ...
... source of major discoveries and breakthroughs in biology, not ... processes. Delegates at a recent research conference organised by ... how technology capable of analysing animal genes across the ... human society. , In breeding both domestic and ...
... WASHINGTON, Oct. 24 ICx Technologies, a developer ... announced,today that it has entered into a new ... Diagnostics to develop diagnostic,sensors. The goal is to ... developed by ICx, and know-how for use in,Siemens, ...
... 24 CME LLC (http://www.CMELLC.com ), a,leading ... 1978, today announced it has been granted five-year ... an approved sponsor of,continuing medical education for APA ... approval as part of the APA,s,Continuing Education in ...
... have discovered a way to use a simple blood ... which gives little warning and is almost always fatal ... Public Library of Science (PLoS), represents the collaborative work ... Diagnostics. , TAAs occur in the part of the ...
Cached Medicine News:Health News:Vangent and Human Arc Win Business With 13 Medicare Part D Plans 2Health News:Vangent and Human Arc Win Business With 13 Medicare Part D Plans 3Health News:Vangent and Human Arc Win Business With 13 Medicare Part D Plans 4Health News:Combination targets: some drugs may work best when they work together 2Health News:Combination targets: some drugs may work best when they work together 3Health News:Combination targets: some drugs may work best when they work together 4Health News:Combination targets: some drugs may work best when they work together 5Health News:Combination targets: some drugs may work best when they work together 6Health News:Combination targets: some drugs may work best when they work together 7Health News:Not just humans benefit from animal biotechnology 2Health News:Not just humans benefit from animal biotechnology 3Health News:ICx Technologies and Siemens Medical Solutions Diagnostics Enter In Vitro Diagnostics Development and License Option Agreement 2Health News:CME LLC Granted Five-Year Full Approval by the American Psychological Association 2Health News:A new key to detecting deadly aortic aneurysms 2
(Date:5/22/2015)... TORONTO , May 22 2015 /CNW/ - The Taskforce ... are very appreciative of all the hard work that the ... the past six months. This program recognizes the needs of ... receive at least $75,000 a year, tax free, with annual ... will be eligible for annual payments of $100,000 based on ...
(Date:5/22/2015)... mayo de 2015 Dipexium Pharmaceuticals, ... farmacéutica de fase tardía centrada en el ... 0.8%), y colaboradores de investigación clínica, han ... el diseño innovador de los ensayos pivotales ... evalúan Locilex®, su nuevo péptido de antibiótico ...
(Date:5/22/2015)... 2015  Effective staffing of key marketing services ... success. Research and consulting leader ... pharmaceutical and biotech marketing managers with metrics detailing ... are being channeled into marketing operations of global ... utilize this report to benchmark their own resource ...
Breaking Medicine Technology:Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 2Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 3Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 4Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 5Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 6Effective Marketing Services Group Critical for Pharmaceutical Brand Recognition 2
... Sciences International, Inc. (Nasdaq: BDSI ) announced ... Officer of BDSI, will present at the Jeffries Global ...  The presentation is scheduled for Thursday, June 9 at ... http://photos.prnewswire.com/prnh/20110217/CL49801LOGO ) Dr. Sirgo will focus on ...
... bioTheranostics, Inc., a bioMerieux company that develops innovative ... today findings from clinical studies utilizing the company,s ... the studies were presented this week at the ... Meeting in Chicago. On June 6, ...
Cached Medicine Technology:BioDelivery Sciences to Present at the Jeffries Global Healthcare Conference 2BioDelivery Sciences to Present at the Jeffries Global Healthcare Conference 3Data from Clinical Studies of bioTheranostics' CancerTYPE ID® and Breast Cancer Index(SM) Molecular Diagnostic Tests Presented at ASCO 2011 Annual Meeting 2Data from Clinical Studies of bioTheranostics' CancerTYPE ID® and Breast Cancer Index(SM) Molecular Diagnostic Tests Presented at ASCO 2011 Annual Meeting 3
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Medicine Products: